Purow BW - Search Results

1

Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling.

Jeon HM, Kim JY, Cho HJ, Lee WJ, Nguyen D, Kim SS, Oh YT, Kim HJ, Jung CW, Pinero G, Joshi T, Hambardzumyan D, Sakaguchi T, Hubert CG, McIntyre TM, Fine HA, Gladson CL, Wang B, Purow BW, Park JB, Park MJ, Nam DH, Lee J. Jeon HM, et al. Among authors: purow bw. Cancer Cell. 2023 Aug 14;41(8):1480-1497.e9. doi: 10.1016/j.ccell.2023.06.007. Epub 2023 Jul 13. Cancer Cell. 2023. PMID: 37451272 Free article.

2

Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions.

Camphausen K, Purow B, Sproull M, Scott T, Ozawa T, Deen DF, Tofilon PJ. Camphausen K, et al. Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8287-92. doi: 10.1073/pnas.0502887102. Epub 2005 May 31. Proc Natl Acad Sci U S A. 2005. PMID: 15928080 Free PMC article.

3

Improving Brain Tumor Research in Resource-Limited Countries: A Review of the Literature Focusing on West Africa.

Ngulde SI, Fezeu F, Ramesh A, Moosa S, Purow B, Lopez B, Schiff D, Hussaini IM, Sandabe UK. Ngulde SI, et al. Cureus. 2015 Nov 3;7(11):e372. doi: 10.7759/cureus.372. Cureus. 2015. PMID: 26677422 Free PMC article. Review.

4

Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies.

Purow B, Staveley-O'Carroll K. Purow B, et al. J Surg Res. 2005 Jan;123(1):49-54. doi: 10.1016/j.jss.2004.04.022. J Surg Res. 2005. PMID: 15652950

5

Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7.

Duex JE, Comeau L, Sorkin A, Purow B, Kefas B. Duex JE, et al. J Biol Chem. 2011 Jul 15;286(28):25377-86. doi: 10.1074/jbc.M111.222760. Epub 2011 May 18. J Biol Chem. 2011. PMID: 21592959 Free PMC article.

6

The landscape of brain tumor mimics in neuro-oncology practice.

Yogendran LV, Kalelioglu T, Donahue JH, Ahmad H, Phillips KA, Calautti NM, Lopes MB, Asthagiri AR, Purow B, Schiff D, Patel SH, Fadul CE. Yogendran LV, et al. J Neurooncol. 2022 Sep;159(3):499-508. doi: 10.1007/s11060-022-04087-4. Epub 2022 Jul 20. J Neurooncol. 2022. PMID: 35857249

7

A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.

Sherman JH, Redpath GT, Redick JA, Purow BW, Laws ER, Jane JA Jr, Shaffrey ME, Hussaini IM. Sherman JH, et al. Among authors: purow bw. J Neurosci Methods. 2011 May 15;198(1):99-102. doi: 10.1016/j.jneumeth.2011.03.003. Epub 2011 Mar 23. J Neurosci Methods. 2011. PMID: 21402102 Free PMC article.

8

Notch inhibitors as a new tool in the war on cancer: a pathway to watch.

Purow B. Purow B. Curr Pharm Biotechnol. 2009 Feb;10(2):154-60. doi: 10.2174/138920109787315060. Curr Pharm Biotechnol. 2009. PMID: 19199947 Free PMC article. Review.

9

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

Kaley TJ, Wen P, Schiff D, Ligon K, Haidar S, Karimi S, Lassman AB, Nolan CP, DeAngelis LM, Gavrilovic I, Norden A, Drappatz J, Lee EQ, Purow B, Plotkin SR, Batchelor T, Abrey LE, Omuro A. Kaley TJ, et al. Neuro Oncol. 2015 Jan;17(1):116-21. doi: 10.1093/neuonc/nou148. Epub 2014 Aug 6. Neuro Oncol. 2015. PMID: 25100872 Free PMC article. Clinical Trial.

10

A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.

Kumthekar P, Grimm SA, Aleman RT, Chamberlain MC, Schiff D, Wen PY, Iwamoto FM, Gursel DB, Reardon DA, Purow B, Kocherginski M, Helenowski I, Raizer JJ. Kumthekar P, et al. Neurooncol Adv. 2022 Aug 19;4(1):vdac123. doi: 10.1093/noajnl/vdac123. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36225651 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page